nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2D6—Parkinson's disease	0.747	1	CbGaD
Tolterodine—Fesoterodine—CYP2D6—Parkinson's disease	0.00166	0.188	CrCbGaD
Tolterodine—Fesoterodine—ABCB1—Parkinson's disease	0.00119	0.134	CrCbGaD
Tolterodine—Chlorphenamine—SLC6A3—Parkinson's disease	0.00103	0.117	CrCbGaD
Tolterodine—CHRM4—head—Parkinson's disease	0.000965	0.0424	CbGeAlD
Tolterodine—CHRM4—nervous system—Parkinson's disease	0.000914	0.0402	CbGeAlD
Tolterodine—CHRM2—forebrain—Parkinson's disease	0.000904	0.0397	CbGeAlD
Tolterodine—CHRM4—central nervous system—Parkinson's disease	0.00088	0.0387	CbGeAlD
Tolterodine—Atomoxetine—SLC6A3—Parkinson's disease	0.000865	0.0979	CrCbGaD
Tolterodine—Labetalol—CYP2D6—Parkinson's disease	0.000825	0.0934	CrCbGaD
Tolterodine—CHRM1—forebrain—Parkinson's disease	0.000823	0.0361	CbGeAlD
Tolterodine—CHRM2—cardiovascular system—Parkinson's disease	0.000764	0.0336	CbGeAlD
Tolterodine—CHRM5—head—Parkinson's disease	0.000754	0.0331	CbGeAlD
Tolterodine—Brompheniramine—CYP2E1—Parkinson's disease	0.000751	0.085	CrCbGaD
Tolterodine—CHRM3—forebrain—Parkinson's disease	0.000736	0.0323	CbGeAlD
Tolterodine—CYP2D6—hindbrain—Parkinson's disease	0.00072	0.0316	CbGeAlD
Tolterodine—CHRM5—nervous system—Parkinson's disease	0.000715	0.0314	CbGeAlD
Tolterodine—CHRM4—brain—Parkinson's disease	0.000699	0.0307	CbGeAlD
Tolterodine—CHRM1—cardiovascular system—Parkinson's disease	0.000696	0.0305	CbGeAlD
Tolterodine—CHRM5—central nervous system—Parkinson's disease	0.000688	0.0302	CbGeAlD
Tolterodine—KCNH2—forebrain—Parkinson's disease	0.000653	0.0287	CbGeAlD
Tolterodine—KCNH2—cardiovascular system—Parkinson's disease	0.000552	0.0242	CbGeAlD
Tolterodine—Brompheniramine—CYP2D6—Parkinson's disease	0.000551	0.0624	CrCbGaD
Tolterodine—CHRM5—brain—Parkinson's disease	0.000546	0.024	CbGeAlD
Tolterodine—Chlorphenamine—CYP2D6—Parkinson's disease	0.000541	0.0612	CrCbGaD
Tolterodine—CHRM2—head—Parkinson's disease	0.000517	0.0227	CbGeAlD
Tolterodine—Atomoxetine—HTR2A—Parkinson's disease	0.000497	0.0563	CrCbGaD
Tolterodine—CHRM2—nervous system—Parkinson's disease	0.000491	0.0215	CbGeAlD
Tolterodine—Orphenadrine—CYP2E1—Parkinson's disease	0.000473	0.0535	CrCbGaD
Tolterodine—CHRM2—central nervous system—Parkinson's disease	0.000472	0.0207	CbGeAlD
Tolterodine—KCNH2—medulla oblongata—Parkinson's disease	0.000472	0.0207	CbGeAlD
Tolterodine—CHRM1—head—Parkinson's disease	0.000471	0.0207	CbGeAlD
Tolterodine—Atomoxetine—CYP2D6—Parkinson's disease	0.000454	0.0515	CrCbGaD
Tolterodine—CYP2C9—cardiovascular system—Parkinson's disease	0.000449	0.0197	CbGeAlD
Tolterodine—CHRM1—nervous system—Parkinson's disease	0.000447	0.0196	CbGeAlD
Tolterodine—KCNH2—midbrain—Parkinson's disease	0.000431	0.0189	CbGeAlD
Tolterodine—CHRM1—central nervous system—Parkinson's disease	0.00043	0.0189	CbGeAlD
Tolterodine—CHRM3—head—Parkinson's disease	0.000422	0.0185	CbGeAlD
Tolterodine—KCNH2—spinal cord—Parkinson's disease	0.000421	0.0185	CbGeAlD
Tolterodine—CYP2D6—brainstem—Parkinson's disease	0.000412	0.0181	CbGeAlD
Tolterodine—CHRM3—nervous system—Parkinson's disease	0.0004	0.0176	CbGeAlD
Tolterodine—CYP2D6—forebrain—Parkinson's disease	0.000398	0.0175	CbGeAlD
Tolterodine—CHRM3—central nervous system—Parkinson's disease	0.000385	0.0169	CbGeAlD
Tolterodine—CHRM2—brain—Parkinson's disease	0.000375	0.0165	CbGeAlD
Tolterodine—KCNH2—head—Parkinson's disease	0.000374	0.0164	CbGeAlD
Tolterodine—KCNH2—nervous system—Parkinson's disease	0.000354	0.0156	CbGeAlD
Tolterodine—CHRM1—brain—Parkinson's disease	0.000341	0.015	CbGeAlD
Tolterodine—KCNH2—central nervous system—Parkinson's disease	0.000341	0.015	CbGeAlD
Tolterodine—KCNH2—cerebellum—Parkinson's disease	0.000333	0.0146	CbGeAlD
Tolterodine—CHRM3—brain—Parkinson's disease	0.000305	0.0134	CbGeAlD
Tolterodine—KCNH2—brain—Parkinson's disease	0.000271	0.0119	CbGeAlD
Tolterodine—CYP2D6—head—Parkinson's disease	0.000228	0.01	CbGeAlD
Tolterodine—CYP3A4—nervous system—Parkinson's disease	0.00022	0.00964	CbGeAlD
Tolterodine—CYP2D6—nervous system—Parkinson's disease	0.000216	0.00949	CbGeAlD
Tolterodine—CYP3A4—central nervous system—Parkinson's disease	0.000211	0.00929	CbGeAlD
Tolterodine—CYP2D6—central nervous system—Parkinson's disease	0.000208	0.00914	CbGeAlD
Tolterodine—CYP2D6—cerebellum—Parkinson's disease	0.000203	0.00893	CbGeAlD
Tolterodine—CYP2D6—brain—Parkinson's disease	0.000165	0.00725	CbGeAlD
Tolterodine—CHRM4—Signaling Pathways—FGB—Parkinson's disease	5.35e-05	0.000241	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—HTR2A—Parkinson's disease	5.33e-05	0.000241	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—DBH—Parkinson's disease	5.33e-05	0.00024	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GBA—Parkinson's disease	5.33e-05	0.00024	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—FBP1—Parkinson's disease	5.33e-05	0.00024	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HTR1A—Parkinson's disease	5.32e-05	0.00024	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	5.3e-05	0.000239	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—ADRBK1—Parkinson's disease	5.28e-05	0.000238	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TAC1—Parkinson's disease	5.24e-05	0.000236	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	5.23e-05	0.000236	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	5.23e-05	0.000236	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PDYN—Parkinson's disease	5.21e-05	0.000235	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	5.16e-05	0.000233	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DRD1—Parkinson's disease	5.14e-05	0.000232	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	5.13e-05	0.000232	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	5.13e-05	0.000232	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—FGB—Parkinson's disease	5.12e-05	0.000231	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—HTR7—Parkinson's disease	5.12e-05	0.000231	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—DRD2—Parkinson's disease	5.12e-05	0.000231	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—HTR2A—Parkinson's disease	5.11e-05	0.00023	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HTR1A—Parkinson's disease	5.09e-05	0.00023	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	5.07e-05	0.000229	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	5.07e-05	0.000229	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TAC1—Parkinson's disease	5.02e-05	0.000226	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DRD3—Parkinson's disease	4.97e-05	0.000224	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DRD1—Parkinson's disease	4.92e-05	0.000222	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	4.92e-05	0.000222	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GFAP—Parkinson's disease	4.9e-05	0.000221	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	4.86e-05	0.000219	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	4.85e-05	0.000219	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GRM5—Parkinson's disease	4.84e-05	0.000219	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	4.8e-05	0.000216	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DRD3—Parkinson's disease	4.76e-05	0.000215	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—ADRBK1—Parkinson's disease	4.64e-05	0.00021	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ND3—Parkinson's disease	4.64e-05	0.000209	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	4.64e-05	0.000209	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	4.55e-05	0.000205	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	4.53e-05	0.000204	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—EDN1—Parkinson's disease	4.51e-05	0.000204	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—DRD2—Parkinson's disease	4.5e-05	0.000203	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HTR7—Parkinson's disease	4.5e-05	0.000203	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	4.47e-05	0.000202	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ADRBK1—Parkinson's disease	4.45e-05	0.000201	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.36e-05	0.000197	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—OMD—Parkinson's disease	4.36e-05	0.000197	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	4.31e-05	0.000195	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HTR7—Parkinson's disease	4.31e-05	0.000194	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—DRD2—Parkinson's disease	4.31e-05	0.000194	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	4.3e-05	0.000194	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—DDC—Parkinson's disease	4.29e-05	0.000194	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	4.26e-05	0.000192	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—FGF20—Parkinson's disease	4.25e-05	0.000192	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	4.21e-05	0.00019	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.13e-05	0.000187	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	4.13e-05	0.000186	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CYP2D6—Parkinson's disease	4.13e-05	0.000186	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ADORA2A—Parkinson's disease	4.12e-05	0.000186	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	4.11e-05	0.000185	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	4.1e-05	0.000185	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	4.08e-05	0.000184	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	4.06e-05	0.000183	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CTGF—Parkinson's disease	4.05e-05	0.000183	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GSTA4—Parkinson's disease	4.05e-05	0.000183	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4e-05	0.00018	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	3.96e-05	0.000179	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	3.95e-05	0.000178	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—DDC—Parkinson's disease	3.95e-05	0.000178	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.94e-05	0.000178	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—DDC—Parkinson's disease	3.91e-05	0.000177	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	3.91e-05	0.000176	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—INSR—Parkinson's disease	3.81e-05	0.000172	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—INSR—Parkinson's disease	3.8e-05	0.000172	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CYP2E1—Parkinson's disease	3.78e-05	0.00017	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IGF2—Parkinson's disease	3.77e-05	0.00017	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—INSR—Parkinson's disease	3.76e-05	0.00017	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—NQO1—Parkinson's disease	3.73e-05	0.000168	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	3.73e-05	0.000168	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GSTA4—Parkinson's disease	3.69e-05	0.000167	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—TH—Parkinson's disease	3.68e-05	0.000166	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	3.65e-05	0.000165	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.65e-05	0.000165	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IGF1R—Parkinson's disease	3.64e-05	0.000164	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MAOB—Parkinson's disease	3.61e-05	0.000163	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IGF2—Parkinson's disease	3.61e-05	0.000163	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—FGB—Parkinson's disease	3.6e-05	0.000163	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—EDN1—Parkinson's disease	3.6e-05	0.000163	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	3.6e-05	0.000162	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—FGB—Parkinson's disease	3.59e-05	0.000162	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	3.59e-05	0.000162	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	3.58e-05	0.000162	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	3.57e-05	0.000161	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—FGB—Parkinson's disease	3.56e-05	0.000161	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	3.55e-05	0.00016	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	3.54e-05	0.00016	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CYCS—Parkinson's disease	3.53e-05	0.000159	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	3.53e-05	0.000159	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	3.52e-05	0.000159	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—DBH—Parkinson's disease	3.51e-05	0.000159	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.51e-05	0.000159	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GBA—Parkinson's disease	3.51e-05	0.000159	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IGF1R—Parkinson's disease	3.49e-05	0.000157	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	3.49e-05	0.000157	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	3.46e-05	0.000156	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	3.45e-05	0.000156	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—EDN1—Parkinson's disease	3.45e-05	0.000156	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.44e-05	0.000155	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	3.42e-05	0.000154	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.36e-05	0.000151	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	3.35e-05	0.000151	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	3.34e-05	0.000151	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	3.33e-05	0.00015	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.32e-05	0.00015	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	3.31e-05	0.000149	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NGF—Parkinson's disease	3.31e-05	0.000149	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MAOB—Parkinson's disease	3.29e-05	0.000149	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NGF—Parkinson's disease	3.17e-05	0.000143	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—HTR2A—Parkinson's disease	3.15e-05	0.000142	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.13e-05	0.000141	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	3.13e-05	0.000141	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—COMT—Parkinson's disease	3.13e-05	0.000141	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	3.12e-05	0.000141	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GSTP1—Parkinson's disease	3.11e-05	0.000141	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—MAOA—Parkinson's disease	3.11e-05	0.00014	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	3.09e-05	0.000139	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—HMOX1—Parkinson's disease	3.07e-05	0.000139	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	3.03e-05	0.000137	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	3.03e-05	0.000137	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	3.02e-05	0.000136	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	3.02e-05	0.000136	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HTR2A—Parkinson's disease	3.02e-05	0.000136	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	2.99e-05	0.000135	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	2.99e-05	0.000135	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ABCB1—Parkinson's disease	2.95e-05	0.000133	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—APOE—Parkinson's disease	2.93e-05	0.000132	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GSTM1—Parkinson's disease	2.86e-05	0.000129	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—APOE—Parkinson's disease	2.8e-05	0.000127	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GPX1—Parkinson's disease	2.74e-05	0.000124	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	2.68e-05	0.000121	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CTGF—Parkinson's disease	2.63e-05	0.000119	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—DDC—Parkinson's disease	2.58e-05	0.000116	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	2.54e-05	0.000115	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	2.53e-05	0.000114	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—MTHFR—Parkinson's disease	2.53e-05	0.000114	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	2.51e-05	0.000113	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—INS—Parkinson's disease	2.5e-05	0.000113	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	2.46e-05	0.000111	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	2.45e-05	0.000111	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	2.45e-05	0.000111	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	2.45e-05	0.00011	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.44e-05	0.00011	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	2.43e-05	0.00011	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—NQO1—Parkinson's disease	2.43e-05	0.00011	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	2.43e-05	0.000109	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.42e-05	0.000109	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	2.42e-05	0.000109	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CTGF—Parkinson's disease	2.4e-05	0.000108	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	2.4e-05	0.000108	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—INS—Parkinson's disease	2.4e-05	0.000108	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—TH—Parkinson's disease	2.39e-05	0.000108	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—APOE—Parkinson's disease	2.35e-05	0.000106	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYCS—Parkinson's disease	2.3e-05	0.000104	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.26e-05	0.000102	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	2.24e-05	0.000101	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.23e-05	0.000101	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NGF—Parkinson's disease	2.23e-05	0.000101	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NGF—Parkinson's disease	2.22e-05	0.0001	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—NQO1—Parkinson's disease	2.21e-05	9.99e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	2.2e-05	9.94e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—TH—Parkinson's disease	2.2e-05	9.93e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.19e-05	9.9e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—TH—Parkinson's disease	2.18e-05	9.84e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.17e-05	9.8e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	2.12e-05	9.59e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	2.12e-05	9.56e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.11e-05	9.53e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	2.1e-05	9.46e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYCS—Parkinson's disease	2.09e-05	9.45e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—COMT—Parkinson's disease	2.03e-05	9.18e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	2.02e-05	9.13e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MAOA—Parkinson's disease	2.02e-05	9.11e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—INS—Parkinson's disease	2.01e-05	9.08e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	2e-05	9.01e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—APOE—Parkinson's disease	1.97e-05	8.91e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—APOE—Parkinson's disease	1.97e-05	8.88e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	1.95e-05	8.8e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	1.92e-05	8.65e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.87e-05	8.44e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	1.86e-05	8.41e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.86e-05	8.4e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	1.86e-05	8.39e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.86e-05	8.38e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—COMT—Parkinson's disease	1.85e-05	8.37e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	1.85e-05	8.35e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.85e-05	8.33e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.84e-05	8.31e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.84e-05	8.29e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.82e-05	8.21e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	1.78e-05	8.05e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GPX1—Parkinson's disease	1.78e-05	8.04e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	1.77e-05	8e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.76e-05	7.95e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.75e-05	7.88e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	1.71e-05	7.73e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.71e-05	7.72e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.7e-05	7.65e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—INS—Parkinson's disease	1.69e-05	7.61e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—INS—Parkinson's disease	1.68e-05	7.59e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—INS—Parkinson's disease	1.67e-05	7.52e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.64e-05	7.42e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	1.64e-05	7.4e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.64e-05	7.39e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.62e-05	7.33e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.61e-05	7.28e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.58e-05	7.15e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—APOE—Parkinson's disease	1.53e-05	6.91e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.51e-05	6.82e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.5e-05	6.76e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.48e-05	6.66e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.46e-05	6.59e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—TH—Parkinson's disease	1.44e-05	6.49e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—APOE—Parkinson's disease	1.41e-05	6.35e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—APOE—Parkinson's disease	1.4e-05	6.3e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.38e-05	6.23e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—INS—Parkinson's disease	1.31e-05	5.9e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	1.26e-05	5.67e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	1.25e-05	5.65e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	1.25e-05	5.63e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	1.24e-05	5.61e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	1.24e-05	5.6e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	1.23e-05	5.56e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—COMT—Parkinson's disease	1.22e-05	5.52e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.22e-05	5.49e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.21e-05	5.48e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—INS—Parkinson's disease	1.2e-05	5.43e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.2e-05	5.42e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—INS—Parkinson's disease	1.19e-05	5.38e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	1.15e-05	5.21e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.15e-05	5.2e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	1.15e-05	5.19e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	1.14e-05	5.14e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.12e-05	5.05e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL6—Parkinson's disease	1.09e-05	4.93e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.07e-05	4.83e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL6—Parkinson's disease	1.05e-05	4.72e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	9.89e-06	4.46e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—APOE—Parkinson's disease	9.2e-06	4.15e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—INS—Parkinson's disease	7.86e-06	3.55e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL6—Parkinson's disease	7.37e-06	3.33e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL6—Parkinson's disease	7.35e-06	3.32e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	7.28e-06	3.28e-05	CbGpPWpGaD
